Secukinumab, Pituitary Enlargement and Panhypopituitarism: Are They Related?
{{output}}
Pituitary adenomas are the most common cause of hypopituitarism associated with pituitary enlargement, but other aetiologies have been emerging, namely immune checkpoint inhibitor-induced hypophysitis (ipilimumab, nivolumab and pembrolizumab). Secukinumab is a... ...